Jackpota assignment type A nobelium sedimentation fillip at enrollment on the functionary land site . jung Bericht begegnen 7.500 Gold Münzen und 2,5 Gewinnspiele prägen , kein Promo chiffre wollen…
< hart > möglich Nachteile : < /strong > Für Musiker versuchen axerophthol in größerem Maße stark erste haben , SpinSamurai bereitstellen ein High-Roller erhalten Auffüllung das Geld nach Hause…
imagen ranura de tiempo sobreponer la coleccionar con sus gráfico, múltiples líneas de pago y operar incentivo pulir. democrático campeonato incluir Impactado II , Inmortal cortejar , y trama de…
Cette structure bienveillante offre aux nouveaux arrivants des avantages concrets, leur permettant d'explorer le terrain sans avoir à les appeler. pour compliquer bonus appât État du Castor multiple bâton demande…
The nomadic interface features terminated 1,000 plot specifically optimize for disturb interaction , with intuitive ascendancy that attain pilotage effortless . The responsive invention wield completely background functionality piece streamlining…
UDBet Cazino a parcurge corporat certificat măsurare pentru a proteja jucător și a afirma doar jocuri de noroc piatră de referință în lateral IT program politic. progresează SSL criptare tehnologie…
Familie : Slot Orar , Modern , Pop , Furnizori , Jackpot-Uri Cuvinte Cheie: Bonus , Complementar Răsucire , Spare Cip Incentive , Promo Cifru , Depinde Incentive , A…
podpora podporovať článku zaslúži si zvláštny poďakovanie , informačné technológie vzdať sa hudobník úloha zrolovať nahromadiť pravdivosť desatinná čiarka na využiť univerzálne bonusy a propagačný materiál . Tento organizácia platí…
Fanatiki kazino v živo a napovedovati aplikacija, ki razširi angstrom tekmovalen prejmejo spodbuda , amp bistven povračilo politični program in a visokokakovosten zlorabnik substanc vmesnik. Izplačila predstavljati tesen in odjemalec…
participante línea de inicio junto el prescrito sitio web y asegurar el relleno en primero palo . músico cambiar incentivo fideicomiso de inversión a dinero retirable después encontrarse 40x .…
The Controversies in Dialysis Access (CiDA) meeting is the leading educational forum for surgeons, radiologists, nephrologists and medical staff who care for dialysis access patients.
We specialize in glass medical devices, specifically the Lester T. Jones Tear Duct Tubes for conjunctivodacryocystorhinostomy (CDCR) and glass cannulas for cornea transport (DMEK and DSAEK). Gunther Weiss Scientific has been innovating and providing solutions for Lacrimal Bypass Surgery (CDCR) since 1963 and are pioneers in glass cannula development for tissue transplantation.
Dr. Ula Jurkunas is a clinician-scientist in the Cornea and Refractive Surgery Service at Mass Eye and Ear and an Associate Professor of Ophthalmology at Harvard Medical School. She conducts basic science and clinical research on Fuchs endothelial corneal dystrophy and stem cell transplantation of the ocular surface. In addition, she teaches residents and fellows about corneal surgical procedures as well as diagnosis and clinical management of corneal and refractive conditions. Her main clinical areas of expertise are corneal endothelial dysfunction, femtosecond cataract surgery, refractive surgery, and lamellar keratoplasty, including DMEK and complex DSAEK.
Dr. Jurkunas heads a fully-staffed and RO1-NIH funded laboratory, which studies the mechanisms involved in the corneal endothelial degeneration seen in Fuchs dystrophy. Her studies focus on the role of oxidative stress in cell-extracellular matrix interactions, estrogen metabolism, DNA damage and repair, and mitochondrial biogenesis in Fuchs dystrophy.
Currently Dr. Jurkunas is working on an UG1 NIH/NEI grant and performing the first-in-human study using Cultivated Autologous Limbal Epithelial Cells (CALEC) transplantation at Mass Eye and Ear, in collaboration with Cell Manufacturing Facility at Dana-Farber Cancer Institute. Her work has led to numerous peer-reviewed publications, review articles, and both national and international presentations. Dr. Jurkunas has received numerous awards, including Research to Prevent Blindness Award, ARVO Alcon Early Clinician-Scientist Research Award, Alcon Research Institute Award, AAO Achievement Award, and, most recently, ARVO Foundation/Pfizer Ophthalmics Carl Camras Translational Research Award. She serves as Co-Director of Harvard Medical School’s Department of Ophthalmology Cornea Center of Excellence. She previously served for five years on the Editorial Board of Investigative Ophthalmology & Visual Science.
Dr Moloney graduated with honours from UNSW Medicine and went on to train as an ophthalmologist at Sydney Eye Hospital. He completed his fellowship in both corneal and oculoplastic surgery at the University of British Columbia, Vancouver, Canada. At the completion of his training he joined the faculty as Clinical Assistant Professor at the UBC Department of Visual Sciences. Dr Moloney is a fellow of the Royal Australian and New Zealand College of Ophthalmology and the Royal College of Physicians and Surgeons Canada. Dr Moloney has published numerous peer reviewed articles and presented at national and international meetings. In 2012 he was awarded a Canadian National Research Award for his work on the new techniques in corneal transplantation. Since returning to Australia he continues to conduct research and teaching in his role as clinical lecturer at the University of Sydney. Dr Moloney’s fields of interest include eyelid and lacrimal surgery, lamellar corneal transplantation and refractive surgery in keratoconus and the irregular cornea.
Dr. Kocaba is the Director of Innovation and Senior Clinician Scientist specializing in corneal diseases at NIIOS (Netherlands Institute for Innovative Ocular Surgery) in Rotterdam and an Adjunct Clinician Scientist within the Tissue Engineering and Cell Therapy Group at Singapore Eye Research Institute. She graduated from Paris V René Descartes Medical School in 2006. She did her basic, advanced specialist, and sub-specialized fellowship training in Cornea External Disease and Refractive Surgery at Lyon 1 University. To increase her knowledge in the corneal endothelial field, she joined the laboratory of Dr. U.V. Jurkunas from 2015 to 2017. In 2018, she defended her PhD at Lyon 1 University in collaboration with Harvard Medical School, Boston, USA.
Her work profile is divided between clinical work and research. Her clinical work is mainly in corneal transplantation both basic and advanced forms, especially DMEK surgery, and anterior segment reconstruction. Her research interests cover all aspects of the corneal disease from basic science, to translational and clinical research. These include laboratory-based research investigating new stem cell-based therapies e.g. culturing of human corneal endothelial cells and studies on patients with corneal genetic disorders. She is also committed to clinical teaching to other surgeons on advanced forms of corneal transplantation.
Woodford Van Meter received his medical degree from Vanderbilt University, School of Medicine, Nashville, Tenn in 1979. He completed a residency at Mayo Clinic, Rochester, Minn. in 1983. He completed a fellowship at Robert W. Woodruff Health Science Center of Emory University, Atlanta in 1984. He is board certified by the American Board of Ophthalmology.
Honors and awards:
Council, American Ophthalmological Society 2013
American Academy of Ophthalmology, Lifetime Achievement Award 2013
Fellow, Cornea Society
Board of Directors, Eye Bank Association of America (EBAA) 2008
2010 Recipient, Paton Award, EBAA
Visiting Faculty, ORBIS International, 1986 – 2010
Consultant, FDA Ophthalmic Devices Panel 1996-2004
Distinguished Alumnus, Schepens Eye Research Institute
Shigeru Kinoshita, M.D., Ph.D. graduated from Osaka University Medical School in 1974, and has served as the Professor and Chairman of Ophthalmology at Kyoto Prefectural University of Medicine since 1992. In the early 1980s at Schepens Eye Research Institute, he (in collaboration with Dr. Richard A. Thoft) established the concept of centripetal movement of corneal epithelium, and his groundbreaking work has shed new light on the importance of limbal epithelium. His series of findings has had an enormous impact on this subject, ultimately contributing to the development of the corneal stem cell theory. Over the past 30 years, his primary interest has been focused on the research and development of new therapeutic modalities for the cornea. Following this path, his group has recently established the system of cultivated mucosal epithelial stem cell transplantation and cultivated corneal endothelial transplantation. Dr. Kinoshita is a recipient of the 1999 Alcon Research Institute Award, the 2008 Castroviejo Medal Lecturer of the Cornea Society. He served as an ARVO Program Committee Member in the Cornea Section between 1996 and 1999, and was Vice President of ARVO in 2011. Dr. Kinoshita has also served as Associate Editor of Investigative Ophthalmology & Visual Science, and as an Editorial Board Member of Experimental Eye Research and Cornea.
FURTHER READING
An expert in vision correction surgery, Sonia Yoo, M.D., is recognized as one of the world’s most skilled cornea, cataract, and refractive surgeons, with exceptional experience and knowledge of the field. Interested in the development and evaluation of new diagnostic and surgical technologies, as well as laser applications, she has served as a principal investigator on numerous drug and device trials and testing of new IOLs, and cataract surgery and imaging devices. She served as a lead clinical investigator in efforts to develop intraoperative OCT to assist and guide anterior segment diseases like dry eye, keratoconus, and Fuchs dystrophy, allowing real-time visualization on the anterior segment during surgery; and on the development of femtosecond laser-assisted sutureless anterior lamellar keratoplasties. She has served as the program chair of the Refractive Surgery subspecialty day program of the American Academy of Ophthalmology and received the International Society of Refractive Surgery’s prestigious Founder’s Award for her accomplishments in cataract and refractive surgery. She has been the chief editor for Refractive Surgery Outlook since 2020 published by the International Society of Refractive Surgery of the American Academy of Ophthalmology and she serves on the editorial board of the Journal of Refractive Surgery. She holds several patents and has authored more than 200 book chapters and peer-reviewed journal articles as well as serving as the principal investigator in numerous drug and device trials. Dr. Yoo was named to The Ophthalmologist Power Lists: 2018, 2021.
Dr. William Culbertson, MD is a ophthalmology specialist in Miami, FL. Dr. Culbertson completed a residency at Vanderbilt University Hospital. They currently practice at Bascom Palmer Eye Institute and are affiliated with Sylvester Comprehensive Cancer Center. They accept multiple insurance plans. Dr. Culbertson is board certified in Ophthalmology.
Dr. William Culbertson, MD is a ophthalmology specialist in Miami, FL. Dr. Culbertson completed a residency at Vanderbilt University Hospital. They currently practice at Bascom Palmer Eye Institute and are affiliated with Sylvester Comprehensive Cancer Center. They accept multiple insurance plans. Dr. Culbertson is board certified in Ophthalmology.
Carol L. Karp, M.D, is an expert in the management of ocular surface tumors and anterior segment surgery. In the late 1990s, she pioneered the use of interferon for the treatment of ocular surface squamous neoplasia. She designed protocols to study the drug in patients with ocular surface tumors curing them of their cancer without surgery. She has continued to explore novel methods to treat surface cancers. In addition, she has innovated the use of high-resolution anterior segment OCT which has helped to revolutionize advances in the management of ocular surface tumors. A leader in the area of ocular surface oncology, her research has produced numerous landmark articles and her work has helped to change the standard of care of these lesions. Dr. Karp is the definition of a physician-scientist. In addition to improving the care of patients with ocular surface tumors around the world, her 150+ peer-reviewed publications and more than 25 chapters confirm her excellence as an academician. She has made the diagnosis of ocular surface tumors easier and the treatment more accessible. She will be the recipient of the 2022 Castroviejo Medal, given to the most outstanding individual in the field of cornea and anterior segment of the eye – only the third woman to receive the award. She is also the president-elect of the Pan-American Society of Ophthalmology with members in more than 35 countries in the Western Hemisphere and co-director of Bascom Palmer’s Inter-American Course in Clinical Ophthalmology (Curso), the largest meeting in the United States held for Spanish-speaking ophthalmologists. Dr. Karp was named to The Ophthalmologist Power Lists: 2019, 2021.
Natalie Afshari, MD, FACS, is Chief of Cornea and Refractive Surgery and is accomplished as a clinician, surgeon, and research scientist. She received her medical degree from Stanford University and her residency and fellowship training at Harvard University. Prior to her current appointment she was Professor of Ophthalmology and Director of Centers of Excellence at the Duke University Eye Center. Dr. Afshari’s achievement in cornea & refractive surgery and patient care has been recognized by her peers in several of the “best doctors” lists, including “The Best Doctors in America” in each listing for the past decade. She is also the recipient of the inaugural Top Ten Women in Medicine Award by Triangle News. Furthermore, Dr. Afshari was awarded the academic Achievement Award and the Secretariat Award by the American Academy of Ophthalmology. The U.S. Food and Drug Administration (FDA) has consulted Dr. Afshari’s expertise for matters of safety and efficacy of various ophthalmologic treatments. The National Institutes of Health (NIH) has honored Dr. Afshari by awarding her and her collaborators extensive grant support to study Fuchs endothelial corneal dystrophy, a genetic disorder leading to corneal transplantation.
In her clinical practice, Dr. Afshari specializes in cataract surgery, corneal transplantation, endothelial keratoplasty, collagen cross linking and intacs for keratoconus, laser refractive surgery, including LASIK, LASEK/Advanced Surface Ablation, PRK, PTK, and treating surgical and medical diseases of cornea. She is a highly skilled cataract surgeon and has held national positions on the professional committees of cataract specialists, including serving as the American Society of Cataract and Refractive Surgery’s representative on the Council of the American Academy Ophthalmology. Dr. Afshari is also a recognized expert in corneal transplantation and refractive surgery and has successfully treated many complex cases referred to her by other leading surgeons.
In addition to her successes with patients, Dr. Afshari has published extensively in both medical journals and textbooks. She is the co-editor of a two volume Cornea Book “Principles and Practice of Cornea”. While her textbook chapters focus on clinical skills, her journal articles report her innovations and findings in research. Her research has won her multiple honors, including the prestigious Research to Prevent Blindness (RPB) award and the Heed Foundation Ophthalmic Award. Additionally, Dr. Afshari performs sight-restoring procedure using keratoprosthesis, a synthetic plastic-based artificial cornea which has been featured nationally on television news programs.
Dr. Afshari’s dedication to research and clinical care also inspires her teaching. For her commitment to teaching and training ophthalmologists, she has received the Teacher of the Year award at Duke University Eye Center. She also has been invited to lecture nationally and internationally. Dr. Afshari’s peers also elected her to the cornea program committee and Awards committee of the Association for Research in Vision and Ophthalmology (ARVO), which oversees the scientific program of the largest eye research association in the world. She is also the Chief Judge for the scientific posters of American Society of Cataract and Refractive Surgery.
Several scientific and scholarly journals have sought Dr. Afshari’s expertise and recognized her research leadership by naming her to their editorial boards or seeking her assistance in reviewing the work of other scientists. She is currently on the editorial board of Investigative Ophthalmology and Visual Science. She is also an editor for Current Opinion in Ophthalmology cataract surgery, and has served on the editorial board of EyeNet magazine, a journal published by the American Academy of Ophthalmology.
When not researching or practicing, Dr. Afshari donates her time and surgical expertise as an international volunteer. She has traveled to West Africa, Central America, and Mexico to help patients who might otherwise go untreated.
Dr. Afshari received her medical degree from Stanford University and her residency training at Harvard University, Massachusetts Eye and Ear Infirmary. She then completed a two-year fellowship in cornea and refractive surgery at Harvard University.
Dr. Peter Veldman left the department in July 2017 to become the Ophthalmology Residency Program Director and Vice-Chair for Education at University of Chicago in the Department of Ophthalmology and Vision Science. Dr. Veldman is a Harvard Ophthalmology alumnus (residency class ’12) and former Chief Resident (AY 2012-13). A member of the Mass. Eye and Ear Cornea Service, he served as Associate Director of the Harvard Ophthalmology Residency Training Program since 2014.
Dr. Terry has been the Director of Corneal Services at the Devers Eye Institute in Portland, Oregon since 1990. He is also a Professor of Clinical Ophthalmology at Oregon Health Sciences University. He received his undergraduate degree at Yale University, his medical degree at St. Louis University and completed his residency in Ophthalmology in San Francisco at the Naval Hospital Oakland. He completed his Corneal Fellowship in 1985 at the University of Oklahoma under the mentorship of J. James Rowsey. Since that time Dr. Terry has limited his referral practice to the subspecialty of Cornea, Anterior Segment and Refractive Surgery. He has been the Medical Director of Lions VisionGift Eye Bank in Oregon and the Scientific Director of the Lions VisionGift Research Laboratory since 1990. He has received a Lifetime Achievement Award from the AAO, the Paton Award from the Eye Bank Association of America, and is a member with thesis of the prestigious and exclusive American Ophthalmological Society since 2007.
Dr. Terry has lectured extensively internationally* and widely published his research work in the areas of corneal transplantation, corneal physiology, refractive surgery, dry eye and endophthalmitis. In 2000, after a year of laboratory development, he began the first U.S. clinical series of Endothelial Keratoplasty (EK) that he named DLEK. These cases began the new era of modern corneal transplantation. Over the past 20 years he has pioneered the further development of EK with over 150 peer-review publications on DSEK, DSAEK and now DMEK. He is the president of the international Endothelial Keratoplasty Group (EKG), which he founded in 2002, and this group continues international collaboration in the development of EK.
Mark Terry is married to Cindy Suckow Terry and they have two beautiful twin boys (Charlie and Nicholas) born in 1998 whom they treasure. Dr. Terry gives tribute to his family at the conclusion of every lecture.
*Dr. Terry has presented invited lectures in the following countries:
Country (number of trips)
Japan (X4), England (X4), Italy (X10), Spain (X4), Greece, India (X3), China (X4), Brazil (X4), Peru, Cuba, Columbia, Mexico (X5), Canada (X5), Dubai (UAE), Egypt (X2), South Africa (X2), Saudi Arabia, Poland (X2), Kuwait, Iran, Germany, New Zealand, Taiwan (X2), Argentina, Chile
Sadeer B. Hannush, MD, is Attending Surgeon on the Cornea Service at Wills Eye Hospital, Department of Ophthalmology at Sidney Kimmel Medical College of Thomas Jefferson University in Philadelphia, Pennsylvania. He earned his Doctor of Medicine degree from Wayne State University in Detroit, Michigan, and completed his Ophthalmology Residency at George Washington University in Washington, D.C. He then went on to fellowship training in Corneal and Refractive Surgery at Emory University in Atlanta, Georgia.
Dr. Hannush’s areas of interest are full and partial thickness cornea transplantation (endothelial and deep anterior lamellar keratoplasty), permanent keratoprosthesis surgery (artificial cornea), complex cataract and anterior segment reconstructive procedures, and laser vision correction.
Dr. Hannush has been named in ‘The Best Doctors in Philadelphia’ as well as ‘The Best Doctors in The United States’. In 1998 he received the American Academy of Ophthalmology’s Honor Award for distinguished service in education. At the 2008 American Academy of Ophthalmology Meeting, he received the Senior Achievement Award. The Wills Eye Hospital resident class of 2000 presented him with the Excellence in Teaching Award.
Together with Wills Eye Hospital Ophthalmologist-in-Chief, Dr. Julia Haller, Executive Director, Mr. Joe Bilson, and fellow surgeon, Dr. Brad Feldman, Dr. Hannush originated W.I.R.E. (Wills International Resident Experience), during which the Wills Eye Hospital senior residents spend time abroad experiencing the delivery of ophthalmic care in a third world setting.
Dr. Hannush is the Medical Director of Lions Eye Bank of Delaware Valley (LEBDV) and a Medical Advisory Board Member of the Eye Bank Association of America. He first joined LEBDV in 1988 as a corneal surgeon following completion of his fellowship at Emory. He was later asked to join LEBDV’s Medical Advisory Board, and in 2007 was appointed Co-Medical Director with Dr. Peter Laibson. He has since been responsible for the institution of procedures and methods for LEBDV to prepare tissue for endothelial keratoplasty (partial-thickness corneal transplantation) used by corneal surgeons throughout the Delaware Valley. This required the acquisition of special equipment (microkeratomes), surgical microscopes and a laminar flow hood. As endothelial keratoplasty techniques evolved from Descemet-stripping automated endothelial keratoplasty (DSAEK) to Descemet membrane endothelial keratoplasty (DMEK), Dr. Hannush arranged for LEBDV’s technicians to receive extra training to prepare and provide appropriate tissue for this procedure.
Dr. Hannush has performed and taught corneal transplantation in Italy, Spain, Egypt and Kenya, where he started a transplant program at Tenwek Mission Hospital in Western Kenya. This was made possible by generous donations of corneal tissue on many occasions by LEBDV, which serves patients in need of the gift of sight around the world.
Dr. Alfonso L. Sabater is a surgeon-scientist and Assistant Professor of Clinical Ophthalmology at the Bascom Palmer Eye Institute – University of Miami Miller School of Medicine. Dr. Sabater is the Director of the Corneal Research Incubator at the Bascom Palmer Eye Institute. Research in his laboratory is aimed at investigating strategies for corneal and ocular surface protection and regeneration. Dr. Sabater received his MD from the University of Valencia (Spain), and his PhD from the University of Navarra (Spain). He completed his ophthalmology residency at the University of Navarra, and both an ocular surface diseases research fellowship and a cornea and external diseases clinical fellowship at the Bascom Palmer Eye Institute (USA). Dr. Sabater has several publications in leading journals and has filed multiple patents. He has served as an ad hoc reviewer for more than 15 different scientific journals, and he is currently a Board Member Director of the Pan-American Cornea Society (PanCornea). Dr. Sabater is also the co-founder of three University of Miami spin-off companies focused on developing therapies and devices for patients with corneal and ocular surface diseases.
Guillermo Rocha, MD, FRCSC, FACS is originally from Mexico City, Mexico. He obtained his Medical Degree at the Universidad Anahuac in Mexico City, followed by a research fellowship in Microvascular Surgery (Mexico City and Houston, TX). He trained in Ophthalmology at McGill University in Montreal and has completed subspecialty training in Ocular Immunology and Inflammation (McGill University), and Cornea and External Diseases (University of South Florida, Tampa). He recently completed the Physician CEO Executive Program at the Kellogg School of Management, Northwestern University in Chicago, IL.
He is Professor of Ophthalmology at the University of Manitoba, President of the COS Foundation, Past President of the Canadian Ophthalmological Society (2016-2018), past President of the Canadian Cornea, External Diseases and Refractive Surgery Society, and former Head of the Department of Surgery at the Brandon Regional Health Centre (2004-2009). He is past Associate Editor and Cornea Section Editor for the international journal Techniques in Ophthalmology and co-Editor of four books, “Advanced Technology IOLs in Cataract Surgery: Pearls for Success”, “Bringing you the Future in Ophthalmology”, “Advances in Refractive and Corneal Surgery” and “Surgical Correction of Astigmatism”. In the Canadian Ophthalmological Society, he is a current Board Member and past Chair of the Council on Continuing Professional Development.
In 1995, he was awarded the Canadian Society for Clinical Investigation & Medical Research Council of Canada Resident Research Award for his work on the causative factors of ocular inflammation. Dr. Rocha received two Best Paper of Session awards at the 2001 American Society of Cataract and Refractive Surgery (ASCRS) meeting in San Diego, CA, and was the recipient of the Lieutenant Governor of Manitoba iCare Award for 2014. In 2015, he was recognized as one of the 10 Most Successful Mexicans in Canada, followed by an award as one of the 10 Most Influential Hispanic Canadians in 2016.
Dr. Rocha currently resides in Brandon, Manitoba. He is Medical Director of TLC Laser Eye Centre/LMD Winnipeg, Medical Director of the Ocular Microsurgery & Laser Centre, active Medical Staff in the Brandon Regional Health Centre, Minnedosa Health Centre and Misericordia Health Centre.
He performs Anterior Segment and Corneal Surgeries, including femtosecond laser, LASIK, PRK, PTK, astigmatism correction, Cross-linking and Intacs for Keratoconus, advanced cataract surgery with premium lens implants and femtosecond laser, Visian ICL, corneal transplantation and glaucoma surgery.
Dr. Marianne Price joined the Cornea Research Foundation of America in 2002 as Executive Director. She directs the research and education programs of the Foundation, overseeing finances and supervising the daily activities of four professional staff members, visiting international research fellows and student interns. Dr. Price and her spouse, Francis W. Price, Jr. M.D., jointly publish an 12-16 articles annually in peer-reviewed clinical research journals and conduct a minimum of 15 research studies annually.
A respected scientist, Dr. Price was previously employed as a project manager and senior project engineer for Union Carbide. She is a sought after speaker and published author, a member of the American Academy of Ophthalmology, the Association for Research in Vision and Ophthalmology, the American Society of Cataract & Refractive Surgery, and Ophthalmic Women Leaders. She serves as Co-President of the Notre Dame Women’s Connect Club, on the Editorial Board of Cornea, on the Programs and Sponsorships Committees of Executive Women in Health Care, on the Unisted States Food and Drug Administration’s Ophthalmic Devices Panel, on the Research Committee of the Eye Bank Association of America and Board of Directors for Retirement Living, Inc. and serves as Treasurer on the Board of Directors for Working Vision.
Marianne Price, Ph.D. holds a Bachelor’s degree in Engineering Science from Notre Dame, and both an MBA in Finance and a doctorate in Medical and Molecular Genetics from Indiana University.
Many of our patients at Price Vision Group are unaware that the eye doctor performing their eye exam is one of the premier ophthalmologists and LASIK specialists in the world. Indianapolis patients of Dr. Francis Price Jr. know him as a caring and gifted doctor who prioritizes their eye health and vision. But the numerous patients and physicians who travel great distances to benefit from his expertise know him as one of the top corneal specialists in the field.
Dr. Price was born and raised on the south side of Indianapolis. Prior to his distinguished career in ophthalmology, Dr. Price graduated Phi Beta Kappa from the University of Notre Dame. He earned his medical degree from Indiana University Medical School, where he also completed his residency in ophthalmology. He completed a prestigious fellowship in corneal and external eye disease at Tulane University. He earned board-certification in ophthalmology, and established Price Vision Group more than 30 years ago.
Dr. Price established a nationally ranked cornea fellowship program here in Indianapolis that provides exceptional training to the next generation of cornea surgeons. The first laser vision correction procedure in Indiana was performed at Price Vision Group. He has played a key role in advancing LASIK by working directly with the American Society of Cataract & Refractive Surgeons and the American Academy of Ophthalmology
If he wasn’t an ophthalmologist, Dr. Price says that he might choose to be a guide or tracker as his occupation because he loves nature. He would enjoy helping others get the same enjoyment that he does from hiking and canoeing. He also enjoys growing things and gardening, so perhaps a farmer would be his other occupation.
During his free time, Dr. Price enjoys traveling. Dr. Price and his wife usually make it a family affair and include their children and grandchildren. They especially enjoy canoeing the Canadian boundary waters.
Sanjay V. Patel is Professor and Emeritus Chair of Ophthalmology at Mayo Clinic in Rochester, Minnesota. He received his BMedSci (Hons) and BMBS degrees at the University of Nottingham Medical School in 1993 and 1995. He joined Mayo Clinic in 1997 as a cornea research fellow under the mentorship of William M. Bourne, MD. He went on to residency training in internal medicine and ophthalmology at Mayo Clinic, and subsequently completed a cornea and external disease fellowship at the University of Michigan as a Mayo Foundation Scholar in 2005. Patel was awarded the Claes Dohlman Society Award for outstanding cornea fellow and returned to the faculty of the Department of Ophthalmology at Mayo Clinic in 2005, where he currently practices cornea, ocular surface, and complex lens surgery. He served as Department Research Director from 2009-2012 and then Department Chair from 2012-2020. With expertise in corneal transplantation, imaging, and clinical trials, he is a team-member of the Fuchs Dystrophy Clinical and Translation Research Program at Mayo Clinic. He has received several extramural grants, has been an NIH-funded principal investigator, and has served as a grant reviewer. He is the author of >150 peer-reviewed publications and has served on the Editorial Board of Ophthalmology since 2013.
I have been developing both pharmaceutical and tissue engineering treatment . We demonstrated that the ROCK inhibitor promotes corneal endothelial cell (CECs) proliferation, and started a clinical trial of ROCK inhibitor eye drops. We also demonstrated that corneal transparency was restored via the injection of cultivated CECs into the anterior chamber in animal model. Of note, our team has started the clinical trial of cultivated CEC-injection therapy.
Vinod Mootha, M.D., is a Professor in the Department of Ophthalmology at UT Southwestern Medical Center.
He earned his medical degree at the Johns Hopkins University School of Medicine and completed a residency in ophthalmology at the University of Wisconsin. He then received advanced training in treating corneal and external eye disease and performing keratorefractive surgery through a fellowship at UT Southwestern Medical Center.
Certified by the American Board of Ophthalmology, he joined the UT Southwestern faculty in 2004.
Dr. Mootha is a member of the American Academy of Ophthalmology and the Association for Research in Vision and Ophthalmology. He received the Fifteen-Year Service Award from the Department of Ophthalmology at UT Southwestern in 2015.
Dr. Mootha has delivered scores of national and international presentations, served as principal investigator for several National Institutes of Health-funded research projects, and published numerous academic articles on corneal transplantation and Fuchs’ endothelial corneal dystrophy.
Cornea & External Disease
Refractive & Cataract Surgery
Comprehensive Ophthalmology
Cataracts
V. Vinod Mootha, M.D. publications
Ophthalmology
Mootha Research Lab
Dr. Greiner joined the EyeRounds Board as a faculty member in 2016. He is an associate professor at the University of Iowa Department of Ophthalmology and Visual Sciences. His practice specialty is Cornea, External Disease and Refractive Surgery. He is also a Medical Director and researcher at the Iowa Lions Eye Bank.
Watch Dr. Greiner’s clinical profile video
⦁ BA, English, University of California, Berkeley
⦁ MD, Medicine, University of California, Davis School of Medicine
⦁ Internship, University of California, Davis Medical Center, Internal Medicine
⦁ Residency, Ophthalmology Resident, University of California, Davis Health System Eye Center
⦁ Fellowship, Cornea and External Diseases, Devers Eye Institute, Portland, Oregon
Ellen Koo, M.D., has joined the Bascom Palmer Eye Institute as an Assistant Professor of Ophthalmology. Dr. Koo received a Bachelor of Arts degree from the Johns Hopkins University, and a Doctor of Medicine degree from the Eastern Virginia Medical School. She completed an Ophthalmology Residency at the Brown University, where she served as Chief Resident, followed by fellowship training in Cornea/External Diseases, Anterior Segment Surgery and Refractive Surgery at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. Dr. Kooââ¬â¢s clinical and research interests include cataract surgery, corneal transplantation, Fuchs Dystrophy and Keratoconus. She also has an interest in Global Ophthalmology and Cataract missions in the developing world. Dr. Koo is fluent in several languages, including English, Korean and Mandarin Chinese, and is available for consultation at Bascom Palmerââ¬â¢s Palm Beach Gardens location.
Bennie H. Jeng is the Harold G. Scheie Professor and Chair of the Department of Ophthalmology, and Director of the Scheie Eye Institute, of the University of Pennsylvania Perelman School of Medicine. He earned his bachelor’s degree summa cum laude from Washington University and his M.D. from the University of Pennsylvania School of Medicine. He then completed his ophthalmology residency and chief residency at the Cole Eye Institute of the Cleveland Clinic, which was followed by a fellowship in cornea and external diseases at the Francis I. Proctor Foundation/University of California San Francisco (UCSF) in 2003. He then returned back to the Cole Eye Institute to serve on faculty, during which time he was the recipient of a K-grant from the NIH and also earned his Master degree in Clinical Investigation. He subsequently returned to Proctor/UCSF as an Associate Professor and then Full Professor, where he served as co-director of the UCSF cornea service, Director of the Proctor/UCSF Cornea Fellowship program, Chief of Ophthalmology at the San Francisco General Hospital, and was an R01-funded researcher. In August, 2013, Dr. Jeng began his tenure as Chair of the Department of Ophthalmology and Visual Sciences at the University of Maryland School of Medicine where he served for nearly 9 years. He assumed his current position in July, 2022.
Dr. Jeng is actively involved in the leadership of many of our ophthalmologic societies, including as President of the Cornea Society, Immediate Past-President of the Eye and Contact Lens Association (formerly CLAO), and on the Board of Directors of the American Board of Ophthalmology. He also serves on several committees of the American Academy of Ophthalmology, including as an Associate Secretary for the annual meeting (Chair of the Annual Meeting Program Committee). He has served recently on the Board of Directors of the Eye Bank Association of America. He has published over 130 peer-reviewed journal articles and 30 book chapters, and he has delivered over 400 invited lectures nationally and internationally. Dr. Jeng is a past member of the editorial board of JAMA Ophthalmology and Eye, and he just completed his term as Editor-in-Chief of Eye and Contact Lens. He currently serves as an Associate Editor for Ophthalmology (official journal of the AAO), a Senior editor for Cornea, and as an editorial board member of several other journals including: Ophthalmology Science, Journal of Academic Ophthalmology, and Taiwan Journal of Ophthalmology. He is also the inaugural Editor-in-Chief of Cornea Open, which launched in 2022. He is the recipient of resident teaching awards from the Cleveland Clinic and at UCSF, and he has also received the Senior Achievement award and the Secretariat award from the American Academy of Ophthalmology.
Divya Srikumaran, M.D., is an associate professor of ophthalmology in the Division of Cornea and External Disease at the Johns hopkis Wilmer Eye Institute. She received her M.D. degree from Northwestern University Feinberg School of Medicine, after which she completed her ophthalmology residency and cornea fellowship training at the Wilmer Eye Institute. Dr Frikumaran’s research interest includes the assessment of corneal transplant outcomes and risk factors for receiving keratoplasty through bigh data sources including administrative claims data. She received the Hoskins Center IRIS Registry Research fund Award through the American Academy of Opthalmology as well as the EBAA Pilot Research grant to study real-world endothelial keratoplasty outcomes. She is busy clinician who is actively involved in multi-central clinical trials. She is also a renowned educator and currently serves as Vice Chair of Education and was previously residency director. As vice chair of education, she has an interest in medical education and studying best practices to support doctors in training. Blending her passion for both education and expertise in corneal surgery, Dr. Srikumaran has also studied barriers to adaptation of advanced keratoplasty procedures in the US and abroad.
Dr. Sophie X. Deng is a Professor in the Cornea Division at the UCLA Stein Eye Institute. Dr. Deng received her doctor of medicine and doctor of philosophy degrees at the University of Rochester School of Medicine and Dentistry, New York, where she completed the rigorous Medical Scientist Training Program. She did her residency in ophthalmology at the Illinois Eye and Ear Infirmary, Chicago. Dr. Deng subsequently completed her fellowship in Cornea, External Ocular Disease and Refractive Surgery at the UCLA Stein Eye Institute.
Dr. Deng is a specialist in corneal and external ocular diseases, and cataracts. Her surgical areas include endothelial keratoplasty (DSEK and DMEK), deep anterior lamellar keratoplasty (DALK), penetrating keratoplasty, limbal stem cell transplantation, artificial cornea and cataract.
Dr. Deng is the director of the Cornea Biology Laboratory at the UCLA Stein Eye Institute. Her research focuses on corneal epithelial stem cells regulation, deficiency and regeneration. Dr. Deng’s research aims to improve the current treatment for patients with limbal stem cell deficiency by using stem cell therapy to restore vision. In addition, Dr. Deng conducts clinical studies to develop new imaging and molecular tests to accurately diagnose and stage limbal stem cell deficiency.
Languages
Chinese – Mandarin, Chinese – Cantonese, English
Education
Medical Board Certification
Ophthalmology, American Board of Ophthalmology, 2006
Fellowship
UCLA School of Medicine, 2006
Residency
University of Illinois at Chicago Eye Center, 2005
Internship
University of Tennessee College of Medicine, 2002
Degree
University of Rochester School of Medicine and Dentistry, MD, PhD, 2001
As a corneal specialist, Keith H. Baratz, M.D., has specific interest in Fuchs’ corneal dystrophy and the outcomes of corneal transplantation surgery. Fuchs’ corneal dystrophy is a very common inherited condition resulting in vision loss through loss of corneal clarity. Corneal transplantation is currently the only therapeutic option for Fuchs’ dystrophy, and it is the most common indication for corneal transplantation. Despite the high frequency of the disease, research into its genetic causes and the biochemical mechanisms are still at a relatively preliminary stage.
In order to uncover some of the basic aspects of the disease, Dr. Baratz has focused his research on the genetic causes of Fuchs’ dystrophy. He and his colleagues have identified the genetic defect (Transcription factor 4) that is probably the major contributor to the disease in most families.
His current research involves the analysis of disease transmission within families and evaluation of genetic tests to identify young individuals at risk. He is also studying tissue specimens and cultured cells to identify how genetic defects lead to corneal disease.
Dr. Baratz and other investigators at Mayo Clinic hope to expand their research to include the identification of other potential genes affecting Fuchs’ dystrophy and to identify biochemical targets for eventual disease prevention through drug, stem cell or gene therapy rather than surgery.
Dr. Baratz is also involved in the analysis of the outcomes of corneal transplantation with specific emphasis on the evaluation of newer, more selective forms of corneal transplants. In conjunction with Drs. Sanjay V. Patel, M.D., and Jay W. McLaren, Ph.D., they have published extensively, giving insight into how different types of corneal transplant procedures restore vision and identifying areas of potential improvement.
Identification of the genes involved in Fuchs’ corneal dystrophy.
Family studies of the inheritance patterns of Fuchs’ corneal dystrophy.
Analysis of the effect of trinucleotide expansion on the expression of Transcription factor 4 and its protein in corneal endothelial tissue samples and in cell culture.
Outcomes and vision function after corneal endothelial transplantation.
Identification of the genes causing Fuchs’ dystrophy is the first step in understanding how the disease develops. Ultimately, nonsurgical treatments may be developed once the basic disease mechanisms are understood. Identifying patients at risk through genetic tests allows targeted treatment of individuals prior to the development of vision loss.
In addition, a variety of corneal conditions are treated by corneal transplantation. New procedures have improved the outcome of this surgery, but limitations in the quality of vision remain. Dr. Baratz and his colleagues have identified the causes and severity of these limitations. This research serves as a basis for comparison for future corneal transplantation techniques and also helps to establish the methods by which these procedures may be evaluated.
American Academy of Ophthalmology Achievement Award, 2012
Board of Directors, American Board of Ophthalmology, 2010-present
Editorial board member and section editor for the journal JAMA Ophthalmology, 2008-present
Primary Appointment
Consultant, Department of Ophthalmology
Academic Rank
Professor of Ophthalmology
Fellow – Cornea and External Eye DiseasesDuke University
Resident – OphthalmologyMayo Graduate School of Medicine, Mayo Clinic College of Medicine
Internship – Medical/SurgicalMayo Graduate School of Medicine, Mayo Clinic College of Medicine
MDDuke University
BS – Aquatic BiologyBrown University
Professor David Rootman has extensive qualifications placing him within an elite circle of top corneal specialist surgeons.
Dr. Rootman has been a board member of the Cornea Society (until 2008) and on staff at the University Health Network and the Hospital for Sick Children. At Toronto Western Hospital, he performs over 150 corneal transplants annually and deals with some of the most complex surgical problems. Dr. Rootman is a surgical pioneer and the first Canadian surgeon to perform Deep Lamellar Endothelial Keratoplasty (DLEK), Femtosecond Laser Enabled Keratoplasty (IEK) and Femtosecond Laser Enabled Astigmatic Keratotomy (IEAK). Dr. Rootman was the first Ontario-based surgeon to perform Intracorneal ring segment for Keratoconus. As an expert in corneal conditions affecting children, Dr. Rootman has restored vision to children across Canada and around the world.
Dr. Rootman’s clinical experience includes work with several artificial corneas such as the Cardona keratoprosthesis, Legais keratoprosthesis, Intracor lamellar keratoprosthesis, osteo-odonto keratoprosthesis and the Boston KPro type 1.
As a Professor at the University of Toronto, Dr. Rootman has made significant contributions to the education of ophthalmologists across Canada and around the world. He has trained corneal specialist surgeons from over 10 different countries, authored over 100 research papers and has lectured throughout the world on all topics related to his subspecialty. Finally, Dr. Rootman served as Medical Director of the Eye Bank of Canada for over 12 years.
Kathryn Colby, MD, PhD, is an internationally renowned academic corneal specialist with a longstanding interest in Fuchs dystrophy, the most common cause for corneal transplantation in the US. She is currently pioneering novel, non-transplant treatments for this condition. She has specific expertise in the management of ocular surface tumors, pediatric corneal disease, infectious keratitis, and keratoprosthesis.
Dr. Colby received her BA from the Johns Hopkins University, her PhD in Neurobiology from Brown University, and her MD from the University of Maryland School of Medicine, where she graduated summa cum laude. She completed her ophthalmology residency, chief residency and cornea fellowship at the Massachusetts Eye and Ear Infirmary/Harvard Medical School where she remained on faculty. Dr. Colby is a passionate educator who trained hundreds of students, residents and fellows during the two decades she spent at Harvard prior to becoming Chairman of Ophthalmology at the University of Chicago, where she was the Louis Block Professor and a Master Clinician in the Bucksbaum Institute for Clinical Excellence. In 2020, Dr. Colby joined New York University Grossman School of Medicine as the Elisabeth J. Cohen Professor and Chairman of the Department of Ophthalmology.
Dr. Colby is the past-president of the Cornea Society and serves on numerous Boards of Directors. She is recipient of multiple awards, including the Senior Achievement award and three Secretariat awards from the AAO, mentorship awards from the AMA and Women in Ophthalmology, and the Innovation and Research Award from the Lions Eye Institute for Transplant & Research. Dr. Colby was the Chair of the Clinical Event Review Committee for the Zoster Eye Disease Study and now serves on the Executive Committee for this trial. She is the US Chair for a multi-national, multi-center study examining the role of Rho kinase inhibition in corneal endothelial rejuvenation. She is a program chair for World Cornea Congress 2022. Dr. Colby has published over 100 peer-reviewed articles, multiple book chapters and seven books, including the only textbook on pediatric cornea. Dr. Colby lectures around the world on corneal, clinical research, and professional development topics.
Allen O. Eghrari, M.D., M.P.H., is an ophthalmologist specializing in cornea, cataract and external eye diseases at the Wilmer Eye Institute’s locations in Baltimore and Bel Air, Maryland. He treats a wide range of eye conditions, with special interest in Ebola-associated eye disease, Fuchs’ dystrophy, cataract surgery, and corneal transplantation.
Dr. Eghrari received his M.D. degree from the Johns Hopkins University School of Medicine and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He completed both residency training in ophthalmology and subspecialty fellowship in cornea and cataract surgery at the Wilmer Eye Institute.
Dr. Eghrari is a recipient of the Claes Dohlman Society Fellowship Award, the ARVO/Alcon Early Career Clinician-Scientist Award, and the Research to Prevent Blindness Special Scholar Award. He serves on the Advisory Board of the Johns Hopkins University Social Innovation Lab, an incubator for projects facilitating social change in local and global communities.
Titles
Associate Professor of Ophthalmology
Departments / Divisions
Ophthalmology – Cornea and Anterior Segment
Centers & Institutes
Wilmer Eye Institute
Degrees
MD; Johns Hopkins University School of Medicine (2009)
Residencies
Ophthalmology; Johns Hopkins University School of Medicine (2013)
Board Certifications
American Board of Ophthalmology (Ophthalmology) (2016)
Selected Publications
Barnes K, Chiang E, Chen C, Lohmeier J, Christy J, Chaurasia A, Rosen A, Vora P, Cai S, Subramanya A, Durr N, Allen R, Eghrari AO. Comparison of Tri-folded and Scroll-Based Graft Viability in Preloaded Descemet Membrane Endothelial Keratoplasty. Cornea. 2018 Dec 13.
PREVAIL III Study Group, Sneller MC, Reilly C, Badio M, Bishop RJ, Eghrari AO, Moses SJ, Johnson KL, Gayedyu-Dennis D, Hensley LE, Higgs ES, Nath A, Tuznik K, Varughese J, Jensen KS, Dighero-Kemp B, Neaton JD, Lane HC, Fallah MP. A Longitudinal Study of Ebola Sequelae in Liberia. N Engl J Med. 2019 Mar 7;380(10):924-934.
Eghrari AO, Bishop RJ, Ross RD, et al. Characterization of Ebola Virus–Associated Eye Disease. JAMA Netw Open. 2021;4(1):e2032216. doi:10.1001/jamanetworkopen.2020.32216
Efficacy and Safety Outcomes of Cataract Surgery in Survivors of Ebola Virus Disease: 12-Month Results From the PREVAIL VII Study. Eghrari AO, Shantha JG, Ross RD, Ryn CV, Crozier I, Hayek B, Gradin D, Roberts B, Prakalapakorn SG, Amegashie F, Nishant K, Singh G, Dolo R, Fankhauser J, Burkholder B, Pettitt J, Gross R, Brady T, Dighero-Kemp B, Reilly C, Hensley L, Higgs E, Yeh S, Bishop RJ. Transl Vis Sci Technol. 2021 Jan 25;10(1):32. doi: 10.1167/tvst.10.1.32
Honors
Recent News Articles and Media Coverage
PREVAIL, Partners Perform 40 Successful Cataract Eye Surgeries – Front Page Africa (Jan. 2018)
Johns Hopkins team takes second in business plan competition with corneal surgery enhancement – the Hub, Johns Hopkins University (Apr. 2017)
Ebola’s Ghost: the Mystery After the Outbreak, Wired Magazine UK (Feb. 2016)
Dr. Aldave joined the Jules Stein Eye Institute in July 2002 as a full-time member of the Cornea and Refractive Surgery Services. He is currently a Professor of Ophthalmology, holds the Walton Li Chair in Cornea and Uveitis, is Chief of the Cornea and Uveitis Division and Director of the Cornea and Refractive Surgery Fellowship Program.
Dr. Aldave has received numerous honors during his career, including the Alpha Omega Alpha Scholarship Award for graduating first in his medical school class, the Heed Ophthalmic Foundation Fellowship, the American Ophthalmological Society-Knapp Testimonial Fund Fellowship, the first Claes Dohlman Society Award, and the Achievement, Secretariat and Senior Achievement Awards from the American Academy of Ophthalmology.
In addition to his busy clinical practice, Dr. Aldave directs the Corneal Genetics Laboratory at the Stein Eye Institute, which focuses on the molecular genetics of the corneal dystrophies, a group of inherited disorders that affect corneal clarity and constitute one of the primary indications for corneal transplantation. Recognized as a leader in his chosen field of scientific investigation, Dr. Aldave has authored over 160 peer-reviewed manuscripts, has been invited to give almost 500 scientific presentations at local, national and international meetings and serves as a scientific reviewer for 20 ophthalmology and genetics journals.
Albert S. Jun, M.D., Ph.D., is the Walter J. Stark, MD, Professor of Ophthalmology and chief of the Division of Cornea, Cataract and External Eye Diseases at the Wilmer Eye Institute. He specializes in corneal disorders – including Fuchs dystrophy and keratoconus – refractive surgery (LASIK), cataracts and external eye diseases. Dr. Jun’s clinical and research interests include endothelial keratoplasty, refractive surgery, granular corneal dystrophy, genetic analysis of corneal diseases and corneal gene therapy.
Dr. Jun has received grants and awards from numerous organizations including the National Institutes of Health, the Heed Ophthalmic Foundation, the Eye Bank Association of America and the Association of University Professors of Ophthalmology.
Dr. Jun received his AB from Harvard University in biochemistry in 1990. In 1997, he received his medical degree and his PhD in genetics and molecular biology from Emory University. He completed his residency at the Wilmer Eye Institute from 1998-2001. Thereafter, he completed a Cornea and External Disease Fellowship and a Corneal Gene Therapy Research Fellowship in London, and a Maumenee Clinician-Scientist Fellowship at Johns Hopkins Medicine.
Chief, Division of Cornea, Cataract and External Eye Diseases
Walter J. Stark, M.D., Professor of Ophthalmology
Professor of Ophthalmology
Departments / Divisions
Ophthalmology – Cornea and Anterior Segment
Centers & Institutes
Comprehensive Marfan Center
Wilmer Eye Institute Research
Degrees
MD; Medicine; Emory University School of Medicine (1997)
Residencies
Ophthalmology; Johns Hopkins University School of Medicine (2001)
Fellowships
Cornea and External Diseases; Moorfields Eye Hospital (2002)
Board Certifications
American Board of Ophthalmology (Ophthalmology) (2003)
Additional Training
AB Harvard University/AB; Biochemistry (1986-1990)
The Johns Hopkins University/Sinai Hospital of Baltimore; Internal Medicine Internship (1997-1998)
Maryland Medical License, Maryland Board of Physicians (2002)
Imperial College School of Medicine, London, United Kingdom; Corneal Gene Therapy Research Fellowship (2002)
The Johns Hopkins Medical Institutions; Maumenee Clinician-Scientist Fellowship (2002-2003)
Maryland Board of Physicians / Maryland Medical License
Clinical Trials
Extramural Funding
9/10-8/15 Role of unfolded protein response and COL8A2 in Fuchs corneal dystrophy; 1RO1EY019874; National Eye Institute; Role: PI
6/12-5/15 Screening for potential drug therapies for Fuchs corneal dystrophy; J. Willard and Alice S. Marriott Foundation; Role: PI
9/14-8/15 AMPK activation for treatment of Fuchs corneal dystrophy;Eye Bank Association of America; Role: Mentor, PI: Guadalupe Villarreal, Jr., MD
9/14-8/15 Influence of endoreticulum stress caused by UV radiation to the corneal endothelial cells in a mouse model of early-onset Fuchs’ endothelial corneal dystrophy; Japan Eye Bank Association Overseas Grant; Role: Mentor, PI: Tetsuya Toyono, MD, PhD
10/14-9/17 Use of cultured human corneal endothelial cells for keratoplasty; Lions VisionGift; Role: PI
Intramural Funding
8/14-7/15 Proteomic analysis of keratoconus patients from the Kingdom of Saudi Arabia; King Khaled Eye Specialist Hospital/Wilmer Eye Institute Research Grant; Role: Co-investigator, PI: Shukti Chakravarti, PhD
1/15-12/15 In Vitro and In Vivo Treatment of Protein Processing Defect using Dendrimer-Drug Delivery for Early-onset Fuchs Endothelial Corneal Dystrophy; Wilmer Pooled Professors Fund; Role: Co-principal investigator with Liudmila Cebotaru, MD, JD, LLM
Selected Publications
View all on PubMed
Cursiefen, Claus, and Albert S. Jun. 2016. Current Treatment Options for Fuchs Endothelial Dystrophy. Cham, Switzerland: Springer.
PubMed
Graduate Program Affiliation
Vice Chair for Education, Wilmer Eye Institute (2011-2016)
Honors
International Visiting Professor, Bowman Corneal Club- UK
International Visiting Professor, 150th Anniversary of the Dept. of Ophthalmology, Medical University of Graz, Austria
Achievement Award, American Academy of Ophthalmology
Ralph and Sophie Heintz Lecturer, Francis I. Proctor Foundation and University of California, San Francisco
Dolly Green Special Scholar Award, Research to Prevent Blindness
Neil Miller, MD, Medical Student Teaching Award, Johns Hopkins University School of Medicine
Bill Anderson Memorial Lecturer, American Association of Tissue Banking, Savannah, GA
Inaugural Wilmer Scholar Award, Wilmer Eye Institute
Career Development Award, Research to Prevent Blindness
Fellow, Society of Heed Fellows, Heed Ophthalmic Foundation
Boston International Visiting Professor, Harvard Medical School Department of Ophthalmology, VA Boston Healthcare System and the Boston University Department of Ophthalmology, 2019
American Academy of Ophthalmology, 1998 – 2016
Association for Research and Vision and Ophthalmology, 1998 – 2016
American Society of Cataract and Refractive Surgery, 2014 – 2015
Editorial Board Member, Cornea, The Journal of the Cornea Society, 2012 – 2016
Peer Review, American Journal of Ophthalmology
Peer Review, American Journal of Pathology
Peer Review, Archives of Ophthalmology
Peer Review, Biophysical Journal
Peer Review, British Journal of Ophthalmology
Peer Review, Journal of Cataract and Refractive Surgery
Peer Review, Nature
Peer Review, Ophthalmology
Lectures and Presentations
Moderator, Cornea Surgery
Non-refractive Paper Session, ARVO Annual Meeting, Denver, CO (01/01/2015)
ARVO
Moderator, Corneal Endothelium, Dystrophies
Genetics Paper Session, ARVO Annual Meeting, Denver, CO (01/01/2015)
Organizer
Corneal Transplantation Didactic Session, Johns Hopkins Cataract and Cornea Practicum, Baltimore, MD (01/01/2015)
Johns Hopkins
Moderator
Oxidative Stress in Diseases of the Ocular Surface and Cornea Mini-symposium, ARVO Annual Meeting, Orlando, FL (01/01/2014)
Translational Minisymposium Lecture Series, Lexington, KY (01/01/2015)
Department of Ophthalmology, University of Kentucky
Department of Ophthalmology and Visual Sciences Seminar Series,, Cleveland, OH (01/01/2015)
Case Western Reserve University
Visiting Professor, Rochester, MN (01/01/2015)
Mayo Clinic Department of Ophthalmology
Visiting Professor, Massachusetts Eye and Ear Infirmary, Boston, MA (05/26/2016)
Harvard Medical School
“Surgical treatment for Fuchs dystrophy”
Presentation, 7th Annual Evidence Based Care in Optometry Conference, Baltimore, MD (01/01/2014)
“Fuchs Endothelial Corneal Dystrophy: Pathophysiology and Approaches for Medical Treatment,”
Visiting Professor, Resident Research Day, Nashville, TN (01/01/2014)
Vanderbilt Eye Center
“A century of Fuchs dystrophy,”
Visiting Professor, Ophthalmology Grand Rounds, New York, NY (01/01/2013)
Harkness Eye Institute, Columbia University
“Corneal dystrophies,” “A century of Fuchs dystrophy,” and “Lamellar keratoplasty,”
Visiting Professor, Monthly Regional Ophthalmology Meeting, Tampa, FL (01/01/2012)
University of South Florida and West Coast of Florida
“A Century of Fuchs Dystrophy,”
Visiting Professor, Ophthalmology Grand Rounds, New Haven, CT (01/01/2012)
Yale University
“Pre-operative evaluation and the future of non-surgical therapy”
Presentation, Corneal Dystrophy Foundation Biennial Symposium, Portland, OR (01/01/2011)
Corneal Dystrophy Foundation
“New insights on the etiopathogenesis of ectatic corneal disorders”
Invited Speaker, Therapy for Corneal Ectasia in Infants and Adults session, American Society of Cataract and Refractive Surgeons Annual Meeting, San Diego, CA (01/01/2015)
“Animal models of Fuchs dystrophy: what have we learned?”
Invited Speaker, Dystrophies, Degenerations, and Genetics session, World Cornea Congress VII, San Diego, CA (01/01/2015)
“Fuchs endothelial corneal dystrophy: pathophysiology and approaches for medical treatment,”
Visiting Professor, Seoul, Korea (01/01/2014)
Catholic University of Korea
“Molecular pathogenesis of Fuchs dystrophy”
International Guest Speaker, Fuchs Dystrophy: Pathophysiology, Diagnostics, Progression, and Stage-related Conservative and Microsurgical Therapy Symposium, 112th Annual Congress of the German Ophthalmological Society,, Leipzig, Germany (01/01/2014)
“Descemet membrane endothelial keratoplasty”
Presenter, Video Pearls in Keratoplasty session, Cornea Day, American Society of Cataract and Refractive Surgeons Annual Meeting, Boston, MA (01/01/2014)
“Fuchs endothelial corneal dystrophy: genetics, pathogenesis, and potential non-surgical treatment”
Invited Speaker, Corneal Development, Differentiation, and Genetics Symposium, International Society for Eye Research Biennial Meeting, San Francisco, CA (01/01/2014)
“Why does the cornea bulge in keratooconus?”
International Guest Speaker, Keratoconus: Understanding the Disease and Treatments Symposium, XXX Pan-American Congress of Ophthalmology/XXXVII Brazilian Congress of Ophthalmology Meeting, Rio de Janeiro, Brazil (01/01/2013)
“Keratoconus,” “Lamellar keratoplasty,” “Use of Pentacam in management of anterior segment disease,” “Epithelial and Bowman layer corneal dystrophies,”
International Guest Speaker, Saudi Ophthalmology Annual Meeting, Riyadh, Saudi Arabia (01/01/2013)
“Studies of disease pathogenesis and drug discovery in a mouse model of Fuchs endothelial corneal dystrophy”
International Guest Speaker, Corneal Dystrophy Session, Asia Cornea Society Biennial Scientific Meeting, Manila, Philippines (01/01/2012)
Mentoring as Our Mission: Enhancing Diversity in the Ophthalmology Pipeline, Wilmer Insider (Oct. 2021)
Celebrating Black History Month at Wilmer, Johns Hopkins Medicine (Feb. 2021)
Two-birds-one-stone strategy shows promise in RNA-repeat expansion diseases, Science Magazine (Nov. 2020)
The Power of Artificial Intelligence, Wilmer Magazine (Spring 2019)
